We zouden het geweldig vinden als je deel wordt van onze community. Word lid van onze Discord om met ons en andere leden in contact te komen!

Ticker
BRETEC.HE

Price
0.87
Stock movement down
-0.01 (-1.36%)
Company name
Bioretec Oy
Exchange
(HE
,
Currency
EUR
)
Sector
Healthcare >
Medical Devices
Marktkapitalisatie
26.72M
Ent waarde
-
Prijs/Verkoop
-
Prijs/Boek
-
Div opbrengst
-
Div groei
-
Jaren van groei
-
FCF-uitkering
-
Trailing P/E
-
Toekomstige P/E
-
PEG
-
EPS-groei
-
1 jaar rendement
-56.60%
3 jaar rendement
-
5 jaar rendement
-
10 jaar rendement
-
Laatst bijgewerkt: 2025-10-30

DIVIDENDEN

BRETEC.HE keert geen dividend uit

WAARDERING

Waarderingsverhoudingen

Loading...
Gegevens over waarderingsratio's
Trailing P/E-
Prijs tot OCF-
Prijs tot FCF-
Prijs tot EBITDA-
EV tot EBITDA-

Waardering (verkoop/boekwaarde)

Loading...
Waarderingsgegevens (verkoop/boekwaarde)
Prijs tot verkoop-
Prijs te boeken-
EV naar verkoop-

FINANCIËN

AANDELENINFORMATIE

Voorraadgrafiek

Loading...
Koersgegevens
Open0.88
Dagelijks hoog0.89
Dagelijks laag0.86
Dagelijks volume46K
Hoogtepunt aller tijden3.26
1y analistenraming1.70
Beta-
WPA (TTM)-
Dividend per aandeel0.00
Ex-div datum-
Volgende inkomsten datum-

Negatief potentieel

Loading...
Nadeel potentiële gegevens
BRETEC.HES&P500
Huidige prijsdaling vanaf het hoogste punt ooit-73.37%-1.10%
Hoogste prijsdaling-73.37%-19.00%
Datum van hoogste daling30 Oct 20258 Apr 2025
Gemiddelde daling vanaf de top-39.94%-2.76%
Gemiddelde tijd tot nieuwe high-5 days
Max tijd tot nieuwe hoogte265 days89 days
BEDRIJFSGEGEVENS
BRETEC.HE (Bioretec Oy) company logo
Marktkapitalisatie
26.72M
Marktkapitalisatie categorie
Small-cap
Beschrijving
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and ActivaScrew, an absorbable surgical implant that is used in fracture treatment, osteotomy, arthrodesis, and bone graft surgery. It also provides ActivaScrew Cannulated that offers a range of fully threaded and partially threaded cannulated screws for fixation of fractures and osteotomies; ActivaScrew Interference, a tool for multiple uses regarding bone fractures, osteotomies, arthrodesesm, and bone grafts; ActivaScrew Interference TCP, a biocomposite interference screw; and RemeOs Screw, a magnesium screw implants. The company was formerly known as BCI Bioabsorbable Concepts Oy. The company was incorporated in 1998 and is headquartered in Tampere, Finland.
Werknemers
0
Investeerdersrelaties
-
CEO
Land
Finland
Stad
Type aandeel
-
CCC-status
-
Dividendfrequentie
-
EVENEMENTEN EN PRESENTATIES
EvenementenPresentaties
Loading...
HET BEDRIJF BEGRIJPEN
Loading...
BEDRIJFSNIEUWS
Alle nieuwsPersberichten
Bioretec announced on 27 October 2025 that it will adjust and restate its previously reported figures for H1/2025.
31 oktober 2025
On 22 November 2024, Bioretec Ltd ("Bioretec" or the "Company"), announced through a press release a new sales and distribution agreement with Tri-State Biologics ("TSB"), enabling the sale and distri...
27 oktober 2025
On 12 September 2025, Bioretec Ltd ("Bioretec" or the "Company"), announced that the revised timeline of the planned commercialization of the DrillPin in the U.S. was then not expected to have a mater...
27 oktober 2025
Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today that the Centers for Medicare & Medicaid Services (CMS) has granted Transitional Pass-Through Payment (TPT) status for the co...
1 oktober 2025
Bioretec Ltd., a pioneer in bioresorbable orthopedic implants, today announced the appointment of Dr. Christopher W. DiGiovanni to its Scientific Advisory Board (SAB).
4 september 2025
Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today the appointment of Jordy Winters as Vice President of Sales Outside U.S. (OUS; Europe and Rest of the World) and member of th...
2 september 2025
Bioretec Ltd., a pioneer in absorbable orthopedic implants, announced today the appointment of Sarah van Hellenberg Hubar-Fisher as Chief Executive Officer (CEO) effective immediately. Van Hellenberg ...
27 augustus 2025
Bioretec Ltd Company announcement 14 August 2025 at 8.00 am EEST
14 augustus 2025
Bioretec Ltd Company announcement 27 June 2025 at 8.00 am EEST
27 juni 2025
Bioretec Ltd Company announcement 24 June 2025 at 18:30 EEST
24 juni 2025
Volgende pagina